HubSpot reports Q2 results on August 5 with a stock that has staged a dramatic reversal — up 30% in a month — even as the analyst community remains visibly split on whether the recovery is justified.
The short side is giving ground fast. Short interest has fallen nearly 10% over the past week to 10.3% of the float, unwinding a position that was closer to 12% in late June. That retreat coincides directly with the stock's rally, suggesting covering rather than conviction. Despite the elevated absolute level, the borrow market offers little sign of squeeze pressure: availability is deeply loose at roughly 1,750% — meaning there are vastly more shares available to lend than are currently borrowed — and the cost to borrow, while rising 50% over the past week, remains a negligible 0.46%. Shorts are leaving, but not because they're being forced out.
Options positioning adds a layer of caution to an otherwise bullish price tape. The put/call ratio at 1.22 is running above its 20-day average of 1.13 by more than a standard deviation, and hit 1.40 on July 30 — the highest reading of the past year. Traders are paying up for downside protection even as the stock rallies, a pattern consistent with hedging into an uncertain print rather than directional conviction either way. HUBS has gained 16% on the week, broadly in line with highly correlated peers (+12%) and (+13%), though (+28%) and (+21%) have run harder — suggesting sector tailwinds rather than HUBS-specific momentum are driving the move.
The analyst debate is pointed. Wells Fargo downgraded to Equal-Weight on July 20, cutting its target from $300 to $225 — a signal that the Street's more cautious voices see the rally as having outrun fundamentals. Citi maintained its Buy rating but trimmed its target to $217 on July 24, now sitting below the current price of $237. The bull case rests on long-term AI monetisation potential and a durable SMB customer base driving compounding ARR growth. The bear case is harder to dismiss: guidance for FY27 revenue and billings was cut after Q1, the AI strategy has yet to produce measurable conversion uplift, and the persistent difficulty turning free users into paying customers remains the central structural concern. With JP Morgan's target at $425 and Macquarie's at $190, the range of outcomes the Street is pricing is unusually wide for a single name — a reflection of genuine disagreement rather than rounding errors.
Insider activity offers a mild additional headwind for sentiment. The CEO, founder-chairman, and CFO all sold shares at $187 on July 1, before the bulk of the rally, and the executive chairman sold a further $1.9 million worth on July 21. Net insider selling totalled roughly $10.2 million over the past 90 days. These appear to be scheduled disposals rather than panic exits, but there has been no buying to offset them.
The August 5 print is therefore less a question of whether HUBS can beat a lowered Q2 bar and more a test of whether management's commentary on AI-driven conversion trends and FY27 bookings momentum can justify a stock that has already recovered 30% from its post-Q1 lows — or confirm the bears' view that the recent rally has simply run ahead of the fundamentals.
See the live data behind this article on ORTEX.
Open HUBS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
